Working collaboratively to support the NHS’s recovery
The Covid-19 pandemic has seen extraordinary pressures put on the NHS. The impact it has had on those living with long-term conditions in particular has been well documented: increasing waiting times for initial consultations, and in turn referrals, diagnosis and treatment. At AbbVie, we believe all those involved in the healthcare system, including pharmaceutical companies, have a key role to play in working collaboratively to support the NHS’s recovery. Alongside our medicines, we can also identify, develop and implement innovative solutions and practices that can help to ease the burden on services, effectively manage long-term conditions and help achieve the best possible experience and outcomes for patients – this need